A Proof of Concept Study to Evaluate the Additive Effects of HFA-BDP (Qvar) to Fluticasone/Salmeterol (Seretide) on Surrogate Markers of Small and Large Airway Inflammation in Refractory Asthma.
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2012
At a glance
- Drugs Beclometasone; Fluticasone propionate; Prednisolone; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Pharmacodynamics
- 11 Jun 2012 Actual patient number is 15 as reported by ClinicalTrials.gov.
- 24 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 24 Mar 2012 Actual end date (9 Jul 2010) added as reported by European Clinical Trials Database.